Martine A. Rothblatt, Chairperson & CEO at UNITED THERAPEUTICS Corp (UTHR), sold 9,500 shares at $469.74 ($4.5M) on 2026-09-24, disclosed to the SEC on 2026-09-25.
Scheduled sale ($4.5M) by Chairperson & CEO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $469.74 | 640 | $301K | 6.7% |
| 2 | $470.63 | 2,603 | $1.2M | 27.2% |
| 3 | $471.77 | 2,160 | $1.0M | 22.7% |
| 4 | $472.73 | 580 | $274K | 6.1% |
| 5 | $474.01 | 437 | $207K | 4.6% |
| 6 | $475.35 | 320 |
| $152K |
| 3.4% |
| 7 | $476.51 | 280 | $133K | 3.0% |
| 8 | $477.58 | 360 | $172K | 3.8% |
| 9 | $478.61 | 1,480 | $708K | 15.7% |
| 10 | $479.52 | 600 | $288K | 6.4% |
| 11 | $480.33 | 40 | $19K | 0.4% |
| Total | $473.55 avg | 9,500 | $4.5M | 100% |
| Filing → |
| UTHR | SELL | 2026-10-07 | $5.1M | — | Filing → |
| UTHR | SELL | 2026-10-06 | $5.1M | — | Filing → |
| UTHR | SELL | 2026-10-05 | $5.2M | — | Filing → |